Bone growth stimulation devices Market Size, Share & Trends | Industry Report, 2018-2026
Increasing incidence of target diseases
such as diabetes, arthritis across the globe coupled with high incidence of
bone injuries is expected to stimulate market growth
Market Size – USD 1117.0 Million in
2018, Market Growth - CAGR of 5.5%, Market Trends – Product launches and
research for advanced bone stimulation technologies
The Bone growth stimulator market is projected to
grow at a CAGR of 5.5%, in terms of value, from USD 1117.0 Million in 2018 to
reach USD 1,695.3 Million by 2026. Bone growth stimulation is emerging as a
preferred method to stimulate natural healing process of bone through passing
low‑level pulses of electromagnetic energy to the site of injury or fusion.
It provides an alternative for painful ortho-surgical procedures and assist
bone healing, for which preventive & therapeutic bone growth stimulation
technologies are developed by various market players.
The market is driven by several factors that
includes advantages provided by bone growth stimulation techniques over
conventional methods, Increasing incidences of target diseases/condition,
rising demand for minimally invasive surgeries and advancement in bone growth
stimulation technologies. For instance, in June 2017, announced a clinical
trial study for the company’s bone growth stimulator. Similarly, in January
2017, Orthofix received FDA approval and CE Mark Approval for sales of its Bone
Growth Stimulators in the regions.
Further key findings from the report
suggest
- Bone
growth stimulation devices market is rising at a growth rate of 5.9
percent in Asia Pacific followed by North America and Europe. High number
of ortho-procedures in the region coupled with technological advancements
will drive the demand for the market during forecast period across all regions.
- Spinal
Fusion Surgeries are likely to contribute to the overall growth. While
revenue from delayed union & nonunion bone fractures is likely to
increase from around USD 404.5 million to USD 603.0 million by 2026. The
delayed union & nonunion bone fractures segment is expected to grow at
a CAGR of 5.2 percent in the forecast period.
- Asia
Pacific is expected to witness a CAGR of 6.5 percent in the forecast
period. Emerging markets such China and Japan are likely to witness high
growth
- The
lack of well-established medical reimbursements for various bone growth
stimulation procedures in various developing regions is likely to hinder
the market growth
- Key
participants include Orthofix International N.V., Medtronic plc, Zimmer
Biomet Holdings, Inc., Harvest Technologies Corporation, DJO Finance LLC,
Isto Biologics, Arthrex, Inc., Bioventus LLC, DePuy Synthes, and Stryker
Corporation.
To Purchase Full Bone
Growth Stimulator Market Report : https://www.reportsanddata.com/checkout-form/1055
For the purpose of this report, Reports
and Data has segmented the Genetic Editing market on the basis of type,
application, end user and region:
- Type
Outlook (Revenue, USD Million, 2016 - 2026)
- Bone
Growth Stimulation Devices
- External
Bone Growth Stimulators
- Combined
Magnetic Field (CMF) Devices
- Capacitive
Coupling (CC) Devices
- Pulsed
Electromagnetic Field (PEMF) Devices
- Implanted
Bone Growth Stimulators
- Ultrasonic
Bone Growth Stimulators
- Bone
Morphogenetic Proteins (BMP)
- Platelet-rich
Plasma (PRP)
- Application
Outlook (Revenue, USD Million, 2016 - 2026)
- Spinal
Fusion Surgeries
- Delayed
Union & Nonunion Bone Fractures
- Oral
and Maxillofacial Surgeries
- Others
- End
User Outlook (Revenue, USD Million, 2016 - 2026)
- Hospitals
and Clinics
- Home
Care Settings
- Academic
Institutes & Research Centers
- Others
- Regional
Outlook (Revenue, USD Million, 2016 - 2026)
- North
America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Spain
- Italy
- Rest
of the Europe
- Asia
Pacific
- China
- Japan
- India
- Southeast
Asia
- Latin
America
- Brazil
- Middle
East & Africa
Comments
Post a Comment